why choose us

Clinical Trials Search

Showing 7,260 of 132,085 result(s)
Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study.

Status: NOT_YET_RECRUITING

Condition: ARDS, Human

Interventions: A catheter-balloon system will be positioned and calibrated in all included patients.
The second generation esogastric multifunction Nutrivent ca

Date: 2023-10-12

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Status: Completed

Condition: Colonic Neoplasms

Interventions: Japanese pathological investigation

Date: 2023-10-12

Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care

Status: NOT_YET_RECRUITING

Condition: Hepatic Fibrosis

Interventions:

Date: 2023-10-12

Hypotension Prediction Index for Shoulder Surgery in Beach Chair.

Status: Completed

Condition: Hypotension During Surgery

Interventions: In the unblinded HPI group (the intervention group), the arterial waveform and pressure will be displayed on the anesthesia monitor and the HPI on the

Date: 2023-10-12

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Status: Completed

Condition: Rheumatoid Arthritis

Interventions: Administered intravenously

Date: 2023-10-11

Study of 18F-FFNP Breast PET;MRI

Status: Completed

Condition: Breast Cancer

Interventions: 18F-FFNP will be given by a slow infusion (approximately 2 minutes), and the dose administered will be approximately 7 mCi.

Date: 2023-10-11

Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment

Status: Completed

Condition: Opioid Abuse

Interventions: ED-initiated buprenorphine, discharge with naloxone, and warm-hand off referral for continued treatment for individuals with OUD.
This is conside

Date: 2023-10-11

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Status: Completed

Condition: Gram-Negative Bacterial Infections

Interventions: Administered via intravenous (IV) infusion

Date: 2023-10-11

A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers and Adults and Adolescents With OI

Status: Completed

Condition: Osteogenesis Imperfecta

Interventions:

In Part A, participants will receive AGA2115 as a single dose administered as a subcutaneous (SC) injection (5 cohorts) or as an intravenous (IV) i

Date: 2023-10-11